ArticleScientific reports2026
Isolation and functional evaluation of Lacticaseibacillus casei HUMB07381 isolated from traditional khiki cheese as a potential probiotic candidate.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study presents the isolation and molecular identification of a Lacticaseibacillus casei strain isolated from traditional Khiki cheese, which showed 99% 16 S rRNA gene sequence similarity to Lcb. casei strain HUMB07381. To assess its probiotic potential, a comprehensive evaluation was conducted including morphological, physiological, and biochemical characterization. The analyses covered carbohydrate fermentation patterns (49 substrates), enzymatic activity, survival under acidic conditions (pH 2.5, 4.0, and 5.5), and tolerance to bile salt concentrations (0.3-0.7%). The strain's capacity to inhibit Staphylococcus aureus biofilm formation and gene expression was also investigated. Antimicrobial activity of neutral and acidic cell-free supernatants (nCFS and aCFS) was determined against Escherichia coli, Salmonella typhimurium, Shigella dysenteriae, Bacillus cereus, Listeria monocytogenes, and S. aureus via agar disc diffusion, agar well diffusion, double-layer, minimum inhibitory concentration (MIC), and minimum bactericidal concentration (MBC) assays. The isolate was identified as Gram-positive, rod-shaped, catalase-negative, non-spore-forming, non-motile, and gas-negative. It exhibited versatile carbohydrate fermentation, significant enzymatic activity, and survival under simulated gastrointestinal conditions (pH, bile salts, NaCl, and 25-40 °C). Moreover, the strain showed strong cell-surface hydrophobicity, auto-aggregation, co-aggregation, cholesterol reduction, and inhibition of S. aureus adhesion and biofilm formation. It also displayed antimicrobial activity against pathogens, in vitro cytotoxic effects on HT-29, HeLa, and MCF-7 cell lines, and pronounced antioxidant activity. Thus, Lcb. casei HUMB07381 represents a promising candidate for functional probiotic dairy products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.